[Surgical therapy of locally advanced non-small cell lung carcinoma]. / La terapia chirurgica del carcinoma del polmone non-microcitoma localmente avanzato.
Chir Ital
; 47(3): 30-3, 1995.
Article
en It
| MEDLINE
| ID: mdl-8964096
ABSTRACT
Experience during the past 10 years has shown up different opinions on the surgical treatment of patients with stage III non-small cell lung cancer. In the light of high resectability and survival rates (respectively 80.8% and 40% at 2 years in the experience of the Southwest Oncology Group) produced with neoadjuvant therapy (followed by surgery) it appears to be an appealing therapeutic option. Until recently, there have been no large prospective randomized phase III trials to answer the question of whether neoadjuvant therapy is superior to other treatment modalities (surgical resection alone; non-surgical treatment).
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Carcinoma de Pulmón de Células no Pequeñas
/
Neoplasias Pulmonares
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
It
Revista:
Chir Ital
Año:
1995
Tipo del documento:
Article